About this article Cite this article Horowitz, A., Chanez-Paredes, S.D., Haest, X
Schedule (Once Weekly Injection) Upper limit: 12 mg per week is the highest dose used in the major published clinical trials (Phase 2 obesity, Phase 2 type 2 diabetes, and the Phase 3 TRIUMPH-4 and TRANSCEND-T2D-1 studies)
Vasculogenic ED in particular is linked with arterial and endothelial damage, often attributed to systemic inflammation
Studies consistently demonstrate that obese individuals require 2-3 times higher vitamin D doses than normal-weight individuals to achieve equivalent 25(OH)D levels
4.3 CellTox green assay Cell toxicity was evaluated using the CellTox Green fluorescent assay (Promega)
Research remains limited, and the effects of BPC-157 on blood pressure have not been fully established in large human studies